Stock Ticker

  • Loading stock data...

Goldman Sachs Group Inc (NYSE:GS) Key Takeaways from Transcatheter Cardiovascular Therapeutics Conference

Boston, MA 09/16/2014 (wallstreetpr) – Investment advisor, Goldman Sachs Group Inc (NYSE:GS) analysts have provided key takeaways from the 2014 Transcatheter Cardiovascular Therapeutics or TPT conference. Accordingly, they have retained their Buy rating on the shares of Abbott Pharmaceuticals (NYSE:ABT) and Edwards Lifesciences Corp (NYSE:EW) while they remained Neutral on St. Jude Medical, Inc. (NYSE:STJ) […]

Edwards Lifesciences Corp (NYSE:EW) Got Approval From FDA To Launch SAPIEN XT Valve In The U.S.

Boston, MA 06/18/2014 (wallstreetpr) – Edwards Lifesciences Corporation (NYSE:EW) on June 16, 2014 announced receiving approval from the United States Food and Drug Administration (FDA) for Edwards SAPIEN XT transcatheter aortic heart valve. This will be used in the treatment of inoperable and high-risk patients who suffer from chronic symptomatic aortic stenosis (AS). Edwards SAPIEN […]

Goldman Sachs Group Inc (NYSE:GS) Sees More Clarity On Edwards Lifesciences Corp (NYSE:EW) Outlook After SAPIEN XT Approval

Boston, MA 06/18/2014 (wallstreetpr) – Investment brokerage Goldman Sachs Group Inc (NYSE:GS) sees more clarity on the outlook of the medical technology company Edwards Lifesciences Corp (NYSE:EW) after the company has received approval from the Food and Drug Administration or FDA for SAPIEN XT, its next generation product of trans catheter aortic valve replacement or […]

Medtronic, Inc. (NYSE:MDT) Settles Fight for Heart Valve Patent with Rival Edwards

Boston, MA 05/22/2014 (wallstreetpr) – The patent litigation was settled between rivals Medtronic, Inc. (NYSE:MDT) and Edwards Lifesciences Corp (NYSE:EW). Medtronic agreed to pay around $1 billion to its rival for settling this litigation. This also allowed Medtronic to keep the CoreValve artificial heart valve in the United States market. The announcement for the settlement […]

Medtronic, Inc. (NYSE:MDT) To Benefit From Use Of Artificial Valves

Boston, MA 04/08/2014 (wallstreetpr) – Medtronic, Inc. (NYSE:MDT) stocks could see a significant uptick after recent studies were released to show that the new range of artificial valves could see significant usage increase as procedures and valves are being used in a way that they can be inserted into the heart without making major surgical procedures […]

Move over heart surgery- Edward’s Sapien device is here!

Boston, MA 03/12/2013 (wallstreetpr) – The Sapien device manufactured by Edwards Lifesciences Corp (NYSE:EW) is as effective and safe as an open heart surgery and has the capacity to last for at least three years say researchers. This device is implanted in the heart to fix a diseased aortic valve and a catheter is used […]

Sunshine Heart (NASDAQ:SSH) Device Receives Approval From FDA- SSH, ABMD, BSX, SPNC, EW

Sunshine Heart Inc (NASDAQ:SSH) announced on Tuesday that it got unconditional authorization from the Food and Drug Administration to start its pivotal U.S. trial for its flagship C-Pulse Heart Assist System. Shares climbed 17 percent premarket to $7.74. As of Monday’s close, the stock was dropped 4.5 percent over the previous three months. Accordant to […]

Sign Up To Get Our Latest Stocks Alerts